INSERM in the news

Participatory research at Inserm actively involves citizens and patient organizations in co-creating scientific knowledge and improving clinical research processes.

Inserm will host a webcast on October 13, 2026, to discuss menopause, its effects, and new therapeutic approaches, featuring experts from various fields.

This article details the financial evolution of major French research institutions from 2016 to 2025, based on data journalism.

Inserm Magazine N°70 explores the need for improved research and care regarding menopause and andropause.

Inserm highlights optogenetics following the 2026 Nobel Prize, detailing its function and successful partial vision restoration in a patient with retinitis pigmentosa.

Inserm opens a regional office in Tokyo and establishes new scientific partnerships with Japanese institutions to enhance biomedical research collaboration between France and Japan.

Inserm opened its Asian regional office in Tokyo and signed four major scientific agreements to strengthen Franco-Japanese biomedical research cooperation.

A clinical trial in Nigeria demonstrated that combining monthly nutritional supplements with vaccination services significantly improved measles vaccination coverage and reduced undernutrition in children.

Researchers identified a mitochondrial mechanism responsible for the long-term psychological effects of adolescent cannabis exposure, specifically linking THC to decreased mitochondrial activity and the dephosphorylation of the NDUFS4 protein in male mice.

The 35th Fête de la Science in Nouvelle-Aquitaine will explore science, taste, food, and health through free public events and school visits from October 2 to 12, 2026.

Inserm has published a four-book series for children aged 8-10, explaining the human body through personified cells and microbes based on scientific research.

Inserm is leading the Darvac project to develop non-viral cancer vaccines by leveraging 'ghost proteins' from the dark genome to boost the immune system before cancer onset.

Ingrid Diogo-Midoux donated 3,000 euros to INSERM for glioblastoma research, honoring her late husband Arnaud, who died from the disease.

Inserm's research teams are making advancements in understanding and treating breast cancer, including therapies for aggressive forms, metastasis prevention, and investigating environmental risk factors.

Researchers have developed an AI-powered algorithm using a finger pulse oximeter to accurately analyze sleep patterns, offering a simpler alternative to traditional polysomnography for diagnosing sleep disorders.

Aline Moulin is appointed as the new regional delegate for Inserm in Provence-Alpes-Côte d'Azur and Corsica, starting September 1, 2026.

Inserm and Université Clermont Auvergne researchers discovered that mechanical allodynia in neuropathic pain may stem from the activation of previously dormant polymodal neurons in the spinal cord, which can interpret touch as pain.

Inserm has launched a new educational kit to empower teenagers in France to critically assess health information found online and on social media.

Michel Desmurget, a research director at Inserm, discusses the PISA 2025 report, revealing a significant decline in French students' academic performance, which he attributes to excessive screen time, digital environments, and a lack of political action, warning of severe economic and democratic consequences.